Immunogenicity of Varicella Vaccine and Immunologic Predictors of Response in a Cohort of Elderly Nursing Home Residents
Conclusions. The Oka/Merck varicella vaccine induces VZV immunity in elderly nursing home residents that is similar to that produced in community-dwelling seniors.
Clinical Trials Registration. NCT01328548.
Source: The Journal of Infectious Diseases - Category: Infectious Diseases Authors: Lelic, A., Verschoor, C. P., Lau, V. W. C., Parsons, R., Evelegh, C., Bowdish, D. M., Bramson, J. L., Loeb, M. B. Tags: VIRUSES Source Type: research
More News: Allergy & Immunology | Clinical Trials | Cytomegalovirus | Infectious Diseases | Merck | Nurses | Nursing | Vaccines | Varicella-Zoster Virus Vaccine